top of page
Executive Spotlights

Pfizer in Talks to Buy Seagen for upwards of $30B

New York, NY, February 27, 2023 (Reuters) -- Pfizer Inc is in early-stage talks to acquire cancer drugmaker Seagen Inc in a potential multi-billion dollar deal, the Wall Street Journal reported, after advanced discussions between Merck and Seagen fell through last year.

Read full article here.

Recent Posts

See All
Life Science Headlines
bottom of page